Connection

R. Amanda Larue to Cancer Vaccines

Back to Details
This is a "connection" page, showing publications R. Amanda Larue has written about Cancer Vaccines.
R. Amanda Larue
Connection Strength
0.038
Cancer Vaccines
  1. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. Vaccine. 2018 10 08; 36(42):6262-6269.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.